Search Results
Mar 02, 2026, 03:50 ET Ultragenyx Pharmaceutical Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RARE
RARE ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of RARE during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 02, 2026, 02:06 ET MGM Healthcare Malar, Adyar Performs Life-Saving Liver Transplant on 8-Month-Old Infant with Severe Liver Complications
Bhat, COO & Vice President – Group Strategic Initiatives, MGM Healthcare Malar, Adyar, stated, "We are immensely proud to have achieved this rare and complex milestone. This successful surgery reflects the seamless coordination of our multidisciplinary teams and demonstrates that critical pediatric
More news about: MGM Healthcare Malar
Mar 02, 2026, 01:01 ET Robotic-assisted arthroplasty shows higher patient satisfaction and quality of life for total knee replacement; comparable infection rates to conventional surgery for total hip replacement
The Safety and Efficiency of Robotic Techniques in THAPeriprosthetic joint infection (PJI) and superficial site infection (SSSI) remain rare but serious complications following THA. One concern surrounding robotic-assisted THA (raTHA) is whether increased operative time could increase the
More news about: American Academy of Orthopaedic Surgeons
Mar 01, 2026, 20:38 ET The Pitt Stars Fiona Dourif and Alexandra Metz Shine in LAGOS Jewelry at the 32nd Annual Actor Awards
own; a nod to the glamour and artistry of the 1920's, and a true statement for the occasion. To complete the narrative, we needed something equally rare and distinctive. LAGOS's one-of-a-kind and inspired pieces felt kismet! The perfect pairing to honor both the era and the moment," said Devin Roc, Metz's
More news about: LAGOS
Feb 28, 2026, 14:18 ET Norgine accoglie con favore il parere positivo del CHMP che raccomanda l'approvazione di mavorixafor nell'Unione europea per la sindrome WHIM
dollari. In Norgine, l'innovazione guida la nostra missione: fornire farmaci che cambiano la vita. Dalle patologie comuni come la stitichezza alle malattie rare e gravi come il cancro infantile, ci concentriamo sulle esigenze mediche non soddisfatte perché crediamo che ogni scoperta scientifica meriti di raggiungere
More news about: Norgine
Feb 28, 2026, 09:45 ET Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis
Systemic Mastocytosis (Abstract 517 – Saturday, February 28)About Systemic MastocytosisSystemic mastocytosis (SM) is a rare disease driven by the KIT D816V mutation in about 95 percent of cases. Uncontrolled proliferation and activation of mast cells result in chronic, severe
More news about: Blueprint Medicines, a Sanofi company
Feb 27, 2026, 22:08 ET Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NasdaqGS: RARE) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Feb 27, 2026, 20:00 ET U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
Prescribing Information, including Boxed Warning.About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael,
More news about: BioMarin Pharmaceutical Inc.
Feb 27, 2026, 17:30 ET Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates
our Phase 1b trial and are optimistic that this candidate has the potential to be a life-changing innovation for people with Netherton syndrome, a rare, autosomal recessive disease, a chronic condition characterized by severe inflammation, pruritus, scaling, red, and dehydrated skin with no known cure
More news about: Azitra, Inc.
Feb 27, 2026, 16:16 ET FCS Foundation Marks Rare Disease Day to Elevate Awareness and Support for Families Living with Familial Chylomicronemia Syndrome
/PRNewswire/ -- Rare Disease Day, observed each year globally on the last day of February to shine a spotlight on the millions of individuals affected by rare conditions, gives the FCS Foundation an important platform to raise awareness about Familial Chylomicronemia Syndrome (FCS) — a rare genetic metabolic
More news about: FCS Foundation
Feb 27, 2026, 15:51 ET FDA approves Novo Nordisk's Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications
advancing care in rare diseases led us to the development of Sogroya® – a once‑weekly growth hormone therapy – which may help address the challenge of daily injections while offering patients and families a therapeutic option that delivers efficacy and safety," said Nicky Kelepouris, Rare Endocrine
More news about: Novo Nordisk
Feb 27, 2026, 14:07 ET Geographic Solutions Earns the Top Prize at The DaVinci Awards®
infrastructure design reflect thoughtful engineering and strategic clarity."Whittall commented further stating, "Three-star distinction recognizes rare, benchmark-level innovation with proven societal and technological impact. Geographic Solutions has delivered something genuinely transformative."Geographic
More news about: Geographic Solutions, Inc.
Feb 27, 2026, 12:42 ET UNESCO warns about the impact of port development on World Heritage site in Panama The Oxygen Project reports
The United Nations Educational, Scientific and Cultural Organisation (UNESCO) warning follows fears across Panama that the port could damage a rare and protected mangrove forest, and other protected areas including Coiba National Park.UNESCO has urged Panama's government to reassess the impact
More news about: The Oxygen Project
Feb 27, 2026, 11:01 ET Flux Marine Appoints Strategy Powerhouse Gary Lancina to Advisory Board
build a brand that defines the future of boating."A Fulbright Scholar with an MBA from Clemson University, the former Mercury executive brings a rare blend of academic rigor and "boots-on-the-dock" industry experience. His appointment reinforces Flux Marine's position as the most exciting—and commercially
More news about: Flux Marine
Feb 27, 2026, 11:00 ET Dr. Jeff Heddles & EB Research Partnership Launch Matter of Time $1 Million Match to Accelerate EB Treatments and a Cure
EB is a rare, painful genetic disease that makes skin as fragile as butterfly wings. Nearly 95% of the 400 million people living with a rare disease still have no FDA-approved treatment, but EB is now among the small fraction of rare diseases with three or more FDA -
More news about: EB Research Partnership
Feb 27, 2026, 10:15 ET Metal Fabrication Market size to Hit USD 32.47 Billion by 2032 at 4.7% CAGR, Reports Maximize Market Research
Reports:Global Rare-Earth Metals Market: https://www.maximizemarketresearch.com/market-report/rare-earth-metals-market/122166/Global Sheet Metal
More news about: Maximize Market Research Pvt. Ltd.
Feb 27, 2026, 09:51 ET Summit Explore Launches Seed Financing Round to Build a New Generation of Western Lithium Brine Projects
project deemed economically viable. This alignment accelerates execution while reducing the total capex burden."Summit Explore offers investors a rare combination: low‑cost resource development, best‑in‑class extraction technology, and a capital structure designed to scale efficiently," said Amanda
More news about: Summit Explore Corporation
Feb 27, 2026, 09:50 ET Why Rare Earth Magnets Are the Real Battlefield Between the U.S. and China
class of qualified heavy rare earth metals and alloys. And in our opinion it is unlikely they will have the capabilities to do so at scale for at least another 3 years.Heavy rare earths keep modern
More news about: OilPrice.com
Feb 27, 2026, 09:19 ET Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
newly independent, publicly traded company dedicated to delivering RNA therapeutics directly to the heart to transform care for people living with rare, life-threatening genetic cardiomyopathies. Atrium Therapeutics was established in connection with Avidity Biosciences, Inc.'s acquisition by Novartis
More news about: Atrium Therapeutics
Feb 27, 2026, 09:15 ET Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida State University (FSU) College of Medicine, further driving innovation in diagnostics and treatments for rare diseases.
More news about: Illumina, Inc.
Feb 27, 2026, 09:15 ET NeutronX Welcomes National Security Strategy and Defense Acquisition Expert Commander Phil Ehr, U.S. Navy (Ret.), to Board of Advisors
graduate of the Naval War College and former National Security Affairs Fellow at the Hoover Institution at Stanford University, Commander Ehr brings a rare combination of operational command experience and defense acquisition expertise to NeutronX."NeutronX and NextNRG are addressing one of the most
More news about: NeutronX Corp.
Feb 27, 2026, 09:09 ET RARE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026
leading national securities law firm, is investigating potential claims against Ultragenyx Pharmaceutical Inc ("Ultragenyx" or the "Company") (NASDAQ: RARE) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Feb 27, 2026, 09:03 ET Phillips & Associates Leads National Plaintiffs Summit on Harassment
Feb. 27, 2026 /PRNewswire/ -- By mastering the most complex supervisor and executive misconduct cases through a rare fusion of business-driven precision and trauma-informed advocacy,
More news about: Phillips & Associates | Sexual Harassment, Discrimination & Employment Lawyers
Feb 27, 2026, 07:28 ET Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies with CBC and CBD
interest in targeted, rare cannabinoid solutions.By increasing the CBC concentration in its new THC-free gummies and offering multiple formats for cannabinoid pairing, Rare Cannabinoid Company reinforces its position at the forefront of rare cannabinoid innovation.About Rare Cannabinoid CompanyRare
More news about: Rare Cannabinoid Company
Feb 27, 2026, 07:01 ET Norgine welcomes positive CHMP opinion recommending approval of mavorixafor in the European Union for WHIM syndrome
living with WHIM syndrome," said Janneke van der Kamp, Chief Executive Officer, Norgine. "At Norgine, we have built deep expertise in delivering rare and specialty medicines across Europe, Australia and New Zealand and the positive CHMP opinion for mavorixafor reflects the type of innovation our organisation
More news about: Norgine